Abstract
Chest imaging has a central role in the diagnosis and monitoring of sarcoidosis. For staging of pulmonary disease on chest radiograph, Scadding stages are still widely used. High-resolution CT (HRCT), however, is more accurate in visualizing the various manifestations of pulmonary sarcoidosis as well its complications. A generally accepted HRCT scoring system is lacking. Fluorodeoxyglucose F 18 positron emission tomography can visualize disease activity better than conventional makers in a significant proportion of patients. In patients with extensive changes on HRCT but no parenchymal fluorodeoxyglucose F 18 uptake, prudence with regard to initiation or intensification of immunosuppressive treatment is warranted.
Original language | English |
---|---|
Pages (from-to) | 603-619 |
Number of pages | 17 |
Journal | Clinics in chest medicine |
Volume | 36 |
Issue number | 4 |
DOIs | |
Publication status | Published - Dec 2015 |
Keywords
- Sarcoidosis
- Chest radiography
- HRCT
- FDG PET/CT
- Disease activity